C.Light Technologies

C.Light Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

C.Light Technologies, founded in 2015 and based in Berkeley, California, is pioneering next-generation retinal imaging. The company's core focus is on developing diagnostic systems that capture dynamic, functional data from the retina, aiming to detect neurological and ocular diseases earlier than current static imaging allows. As a private, pre-revenue medical device developer, it targets a significant unmet need in the growing ophthalmic diagnostics market. Its success hinges on clinical validation, regulatory clearance, and adoption by eye care professionals.

OphthalmologyNeurology

Technology Platform

Proprietary high-speed retinal imaging platform designed to capture dynamic, functional data from the retina for early disease detection.

Funding History

2
Total raised:$10M
Series A$8M
Seed$2M

Opportunities

The aging global population and rising rates of diabetes create a large and growing market for advanced ophthalmic diagnostics.
The technology's potential application in neurology offers an even larger addressable market for early detection of neurodegenerative diseases.

Risk Factors

High technical and clinical validation risk to prove utility, significant regulatory hurdles for a novel diagnostic device, and challenges in commercial adoption against established, lower-cost imaging systems.

Competitive Landscape

Competes against large, established medical device companies (e.g., Zeiss, Heidelberg Engineering, Topcon) offering static retinal imaging, and a growing number of startups in AI-based image analysis. Differentiation hinges on capturing unique functional data, not just enhancing static images.